One experiment was performed containing at least 50 counted cell nuclei. Conclusions Combination of 5-aza-dC and differentiation-inducing or epigenetic mediators show promising antitumor effects on metabolic activity of MB cells. Cell line-specific results indicate an important impact of the genetic background, which is known to be extremely

variable in MBs. Further insight in the acting mechanisms, especially of resveratrol, is needed to evaluate the full potential in antitumor therapy and to translate TPX-0005 clinical trial the synergistic effects on short-term metabolic activity into long-term reproductive survival deficiency. References 1. Gibson P, Tong Y, Robinson G, Thompson MC, Currle DS, Eden C, Kranenburg TA, Hogg T, Poppleton H, Martin J: Subtypes of medulloblastoma have distinct developmental origins. Nature 2010, 468:1095–1099.PubMedCrossRef 2. de Bont LBH589 in vivo JM, Packer RJ, Michiels EM, den Boer ML, Pieters R: Biological background of pediatric medulloblastoma and ependymoma: a review from a translational research perspective. Neuro Oncol 2008, 10:1040–1060.PubMedCrossRef 3. Rossi A, Russo G, Puca A, La MR,

Caputo M, Mattioli E, Lopez M, Giordano A, Pentimalli F: The antiretroviral nucleoside analogue Abacavir reduces cell growth and promotes differentiation of human medulloblastoma cells. Int J Cancer 2009, 125:235–243.PubMedCrossRef 4. Yu LJ, Wu ML, Li H, Chen XY, Wang Q, Sun Y, Kong QY, Liu J: Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells. Neoplasia 2008, 10:736–744.PubMedCrossRef 5. Wang Q, Li H, Wang XW, Wu DC, Chen XY, Liu

J: Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells. Neurosci Lett 2003, 351:83–86.PubMedCrossRef 6. Chai G, Li L, Zhou W, Wu L, Zhao Y, Wang D, Lu S, Yu Y, Wang H, McNutt MA: HDAC inhibitors act with 5-aza-2′-deoxycytidine to inhibit cell proliferation by suppressing removal of incorporated abases in lung cancer cells. PLoS One 2008, 3:e2445.PubMedCrossRef 7. Fu YS, Wang Q, Ma JX, Yang XH, Wu ML, Gefitinib ic50 Zhang KL, Kong QY, Chen XY, Sun Y, Chen NN: CRABP-II methylation: a critical determinant of retinoic acid resistance of medulloblastoma cells. Mol Oncol 2012, 6:48–61.PubMedCrossRef 8. Patties I, Jahns J, Hildebrandt G, Kortmann RD, Glasow A: Additive effects of 5-aza-2′-deoxycytidine and irradiation on clonogenic survival of human medulloblastoma cell lines. Strahlenther Onkol 2009, 185:331–338.PubMedCrossRef 9. Hagemann S, Heil O, Lyko F, Brueckner B: Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines. PLoS One 2011, 6:BAY 11-7082 price e17388.PubMedCrossRef 10. Li LH, Olin EJ, Fraser TJ, Bhuyan BK: Phase specificity of 5-azacytidine against mammalian cells in tissue culture. Cancer Res 1970, 30:2770–2775.PubMed 11.